TERRI-ANN REID: Open Payments
NPI 1073744819 · ROSEDALE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 4 payments from 4 companies in 2025. Trend: 2023 $46 · 2024 $333 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 1 | $151 |
| Organon LLC | 1 | $46 |
| Astellas Pharma US Inc | 1 | $30 |
| Grifols USA, LLC | 1 | $15 |
Products named: GEMTESA, NEXPLANON, Veozah, Xembify.
Industry payments across NY — which companies pay providers there.
